In line with S3, CBM promotes an open and inclusive network of actors and contributes to the Regional Innovation Health Ecosystem in the following technological and innovation development roadmaps and priorities:
Biomedical technologies and in vivo diagnostics
The development of medical devices, including diagnostic imaging systems, for the development of new products for advanced biosensors and for prosthetics; creation of biomaterials and bioreactors for regenerative medicine field and development of advanced instrumentation in the field of nanotechnologies.
In vitro diagnostics
The development of innovative technology platforms for human diagnostics and clinical evaluations of patients, for food diagnostics (quality, traceability and safety), and for veterinary and environmental diagnostics in the health sector and the development of “Omic” technologies.
Medical informatics and bioinformatics
The integration of informatics technologies into the development of new systems and software solutions for hospital informatics; social and health informatics; informatics for bio-imaging; informatics for medical laboratories; informatics for blood, tissue, and cell banks; and informatics for personalized medicine.
The development of biopharmaceuticals; biosimilars; bio-materials (e.g. for oncological, cardiovascular, metabolic, respiratory, neurodegenerative, andinflammatory diseases. Advanced biotechnological platforms for the production of drugs aimed at the treatment of rare diseases; technologies for cell therapies, gene therapies, and small molecules for personalized therapy; probiotics, prebiotics, synbiotics, and bioactive supplements as proactive, health-promoting foods; and advanced services to support the productions mentioned above, such as in silico methods for molecular modeling and drug toxicity.
Ambient Assisted Living (AAL)
The design of technological solutions to make the personal living environment active, intelligent, and cooperative, products, and services related to telemedicine, telecare, home automation, health aids, and wearable devices, as well as other products and services for the prevention of diseases and disabilities in older adults and the welfare of citizens.
All of these technological innovations and priorities have to be integrated with advanced manufacturing technologies, such as big data, predictive analytics, virtualized processes, modeling and simulation, data security, cloud technologies for healthcare, high-performance computing, and Internet of Things technologies, and with sensor systems in order to offer innovation for monitoring and managing illness and improving wellness.